Vanguard Capital Management’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,791
Closed -$91.6K – 4086
2026
Q2
$91.6K Sell
17,791
-16,031
-47% -$56.8K ﹤0.01% 3883
2026
Q1
$91.3K Buy
+33,822
New +$343K ﹤0.01% 3871

Other funds holding CALC

Vanguard Capital Management's CALC Position: Q3 2026 in Review

Vanguard Capital Management sold out of CalciMedica (CALC) in Q3 2026, closing a stake of 17,791 shares — an estimated $91.6K sold.

Vanguard Capital Management first reported a position in CALC in Q1 2026 and held it in 2 quarters. The position peaked at $91.6K in Q2 2026. 17 funds tracked by Wall St. Rank hold CALC as of Q3 2026.

  • Vanguard Capital Management reported no remaining CalciMedica position as of Q3 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 17,791 CalciMedica shares in Q3 2026, an estimated $91.6K.
  • Vanguard Capital Management first reported a position in CalciMedica in Q1 2026 and held it in 2 quarters.
  • Vanguard Capital Management's CalciMedica position peaked at $91.6K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.